Skip to main content

Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months with Suspected or Confirmed Bacterial Infection

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Critical Care Medicine

Awarded By

Allergan, Inc.

Start Date

March 1, 2016

End Date

November 6, 2019
 

Administered By

Pediatrics, Critical Care Medicine

Awarded By

Allergan, Inc.

Start Date

March 1, 2016

End Date

November 6, 2019